Summary: \u201cIs statin therapy safe for pregnant women?\u201d
\nSource: March 25, 2025
\n1. Historical context: Statins were long prohibited during pregnancy due to FDA \u201cblack box\u201d warnings based on animal studies showing potential birth defects.
\n2. Regulatory change: In 2021, the FDA removed the black box warning after human studies did not confirm a strong link between statins and congenital malformations.
\n3. Rising concern: With increasing maternal obesity and older maternal age, cardiovascular health in pregnant women is now a growing issue. Expert opinion: Dr. Laxmi Mehta emphasizes that many women need statins to manage cardiovascular risk, especially those with FH or existing ASCVD.
\n4. ASCVD and FH prevalence: Atherosclerotic cardiovascular disease affects ~1.4% of women of childbearing age; familial hypercholesterolemia (FH) is often underdiagnosed and untreated.
\n5. New approach: Women with severe lipid disorders should not be automatically discouraged from pregnancy; therapy can be managed safely with medical guidance.
\n6. Current evidence: Some data suggest potential risks like low birth weight or preterm labor, but not congenital abnormalities.
\n7. Shared decision-making: The updated guidelines promote individualized care and open discussions between clinicians and patients regarding statin use during pregnancy.<\/p>\n